← FDA Drug Approvals (Drugs@FDA)

ELESTAT

NDA · New Drug Application · Sponsor: ALLERGAN · Approved 2003-10-16

Drug application

FDA Application #

NDA021565

Application type

New Drug Application

Brand name

ELESTAT

Generic name

Epinastine Hydrochloride

Active ingredients

EPINASTINE HYDROCHLORIDE

Dosage form

SOLUTION/DROPS

Route

OPHTHALMIC

Marketing status

Discontinued

Sponsor

ALLERGAN

First approval

2003-10-16

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown